Back to Press-Releases
Better Science, Better Health Conference to Promote International Collaboration to Accelerate New Models in Healthcare
Vital Transformation is pleased to announce the Better Science, Better Health: New Healthcare Models Conference, which aims to promote international collaboration to accelerate new models in healthcare. Taking place in Washington D.C., from 27-28th October, the Conference features thought leaders who will help shape the future of healthcare in both Europe and the United States.
Better Science, Better Health: New Healthcare Models is jointly organized with and supported by the Drug Information Association (DIA), European Federation of Pharmaceutical Industries and Associations (EFPIA), Innovative Medicines Initiative (IMI), MIT NEWDIGS, and National Organization for Rare Disorders (NORD). The Conference is sponsored by Oracle Health Sciences, ISPOR and Pfizer.
The event follows on the success of the Better Science, Better Health event held at the Royal College of London in October 2014, again bringing together top international decision-makers, this time in the US.
Better Science, Better Health: New Healthcare Models is jointly organized with and supported by the Drug Information Association (DIA), European Federation of Pharmaceutical Industries and Associations (EFPIA), Innovative Medicines Initiative (IMI), MIT NEWDIGS, and National Organization for Rare Disorders (NORD). The Conference is sponsored by Oracle Health Sciences, ISPOR and Pfizer.
The event follows on the success of the Better Science, Better Health event held at the Royal College of London in October 2014, again bringing together top international decision-makers, this time in the US.
Confirmed speakers include:
- Sheldon Whitehouse, United States Senator from Rhode Island
- Rob Califf, FDA Deputy Commissioner for Medical Products and Tobacco
- Ruxandra Draghia-Akli, Director Health, DG Research and Innovation, European Commission
- Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency
- Lynn D. Hudson, Chief Science Officer, Critical Path Institute
- Pierre Meulien, Executive Director, Innovative Medicines Initiative
Topics of discussion include:
- New science is driving innovation in new therapies: How can Europe and the US broadly learn from each other regarding their experiences with such models as Breakthrough Designation and the European Medicines Agency (EMA) Adaptive Pathways Pilot?
- Patient access and patient engagement: How can Europe and the US share their experiences for incorporating patient preferences into regulatory practices?
- The ever changing and evolving evidence base, harnessing big data and real world evidence: How can we use existing health data and combine it with other real world evidence to create better, more effective therapies, diagnostics and companion diagnostics?
A full list of speakers and agenda is available on the conference website.
Supported by:
Sponsored by:
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!